Blueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeutics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Physicians should perform graded direct challenges when patients at low risk for a reaction report an antibiotic allergy, according to a review published in Annals of Allergy, Asthma & Immunology. In addition to improving clinical outcomes, these challenges often provide cost and time savings compared with skin testing, Allison C. Ramsey, MD, allergy and clinical immunology, Rochester
Blueprint Medicines (BPMC) Announces NEJM Evidence Publishes Results from Registrational PIONEER Trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Blueprint Medicines Corporation (Nasdaq: BPMC) today announced that NEJM Evidence, a journal from The New England Journal of Medicine Group,.
The Cambridge biotech’s treatment combats an immune and blood condition that causes severe allergic reactions to ordinary things, like a whiff of perfume or an elevated heart rate.